MOTIVATION: Large-scale genotyping relies on the use of unsupervised automated calling algorithms to assign genotypes to hybridization data. A number of such calling algorithms have been recently established for the Affymetrix GeneChip genotyping technology. Here, we present a fast and accurate genotype calling algorithm for the Illumina BeadArray genotyping platforms. As the technology moves towards assaying millions of genetic polymorphisms simultaneously, there is a need for an integrated and easy-to-use software for calling genotypes. RESULTS: We have introduced a model-based genotype calling algorithm which does not rely on having prior training data or require computationally intensive procedures. The algorithm can assign genotypes to...
MOTIVATION: Given the current costs of next-generation sequencing, large studies carry out low-cover...
Affymetrix's SNP (single nucleotide polymorphism) genotyping chips have increased the scope and decr...
Motivation: Modern strategies for mapping disease loci require efficient genotyping of a large numbe...
Motivation: Large-scale genotyping relies on the use of unsuper-vised automated calling algorithms t...
Summary: Genotype calling from high-throughput platforms such as Illumina and Affymetrix is a critic...
Motivation: Next-generation genotyping microarrays have been designed with insights from 1000 Genome...
Summary: Genotype calling from high throughput platforms such as Illumina and Affymetrix is a critic...
Motivation: Preliminary results on the data produced using the Affy-metrix large-scale genotyping pl...
We present a novel method for simultaneous genotype calling and haplotype-phase inference. Our metho...
High-throughput SNP genotyping platforms use automated genotype calling algorithms to assign genotyp...
Genotype microarrays assay hundreds of thousands of genetic variants on an individual's genome. The ...
BACKGROUND: SNP genotyping microarrays have revolutionized the study of complex disease. The current...
Single nucleotide polymorphisms (SNPs) are DNA sequence variations, occurring when a single nucleoti...
Single-nucleotide polymorphisms (SNPs) have been recognized as the marker of choice in genetic studi...
UNLABELLED: Illumina produces a number of microarray-based technologies for human genotyping. An Inf...
MOTIVATION: Given the current costs of next-generation sequencing, large studies carry out low-cover...
Affymetrix's SNP (single nucleotide polymorphism) genotyping chips have increased the scope and decr...
Motivation: Modern strategies for mapping disease loci require efficient genotyping of a large numbe...
Motivation: Large-scale genotyping relies on the use of unsuper-vised automated calling algorithms t...
Summary: Genotype calling from high-throughput platforms such as Illumina and Affymetrix is a critic...
Motivation: Next-generation genotyping microarrays have been designed with insights from 1000 Genome...
Summary: Genotype calling from high throughput platforms such as Illumina and Affymetrix is a critic...
Motivation: Preliminary results on the data produced using the Affy-metrix large-scale genotyping pl...
We present a novel method for simultaneous genotype calling and haplotype-phase inference. Our metho...
High-throughput SNP genotyping platforms use automated genotype calling algorithms to assign genotyp...
Genotype microarrays assay hundreds of thousands of genetic variants on an individual's genome. The ...
BACKGROUND: SNP genotyping microarrays have revolutionized the study of complex disease. The current...
Single nucleotide polymorphisms (SNPs) are DNA sequence variations, occurring when a single nucleoti...
Single-nucleotide polymorphisms (SNPs) have been recognized as the marker of choice in genetic studi...
UNLABELLED: Illumina produces a number of microarray-based technologies for human genotyping. An Inf...
MOTIVATION: Given the current costs of next-generation sequencing, large studies carry out low-cover...
Affymetrix's SNP (single nucleotide polymorphism) genotyping chips have increased the scope and decr...
Motivation: Modern strategies for mapping disease loci require efficient genotyping of a large numbe...